Area of research
Hepatology · Epidemiology
Research interest
Research focused on Coronavirus disease 2019 (COVID-19) and Virology, with related work in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Prospective cohort study, Antibody. Notable publications include 'Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre,...', 'Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19', and 'Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study'.
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
International Pediatric COVID-19 Severity Over the Course of the Pandemic
Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors
The impact of vaccination and SARS-CoV-2 variants on the virological response to SARS-CoV-2 infections during the Alpha, Delta, and Omicron waves in England
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study
Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Epidemiology of SARS-CoV-2 infection among staff and students in a cohort of English primary and secondary schools during 2020–2021
The COVID-19 Schools Infection Survey in England: Protocol and Participation Profile for a Prospective Observational Cohort Study
Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, England
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
Ebola virus antibody decay–stimulation in a high proportion of survivors
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)
Characterising the risk of Hepatitis E virus infection in haematological malignancies: a <scp>UK</scp> prospective prevalence study
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs
Antibody-based assay discriminates Zika virus infection from other flaviviruses
Hepatitis B virus transmission in pre-adolescent schoolchildren in four multi-ethnic areas of England